Promethera Biosciences: Announcement Regarding Business Activities in Japan
Posted Nov 1, 2019 05:19 (GMT +7)
MONT-SAINT-GUIBERT, Belgium & TOKYO--(BUSINESS WIRE)--Oct. 31, 2019
Promethera Biosciences SA (Group), a global innovator in cell-based medicines and liver diseases, announced the foundation of a new branch office in Tokyo, Promethera Biosciences Japan Branch Ltd on May, 2018. Establishing a branch office in Japan marks the starting point for building a strong presence of Promethera in Japan first, initially focusing on increased Business Development, Investor Relations activities and expansion of its business and products pipeline in Japan. This presence will also address the Asian markets as a second step.
As we develop such business activities, we are considering various options for further strengthening our presence in Japan. These options include future listing on the Tokyo Stock Exchange Market (whether or not using a Japanese Depositary Receipt (JDR scheme*) or another Asian stock exchange, and/or partnering with pharmaceuticals.
*for more information of the JDR scheme, please see
https://www.jpx.co.jp/english/equities/listing-on-tse/new/basic/05.html
About Promethera Biosciences:
Promethera Biosciences is a global innovator in liver therapeutics whose mission is to bring life-saving treatments to reduce the need for liver transplantation. Our lead clinical program, derived from our patented cell technology platform HepaStem, is designed to benefit from its immune-modulatory and anti-fibrotic properties. In addition to our cell-based pipeline, we develop antibody technologies such as the antiTNF-R1 antibody Atrosimab, to complement and diversify our therapeutic options. We are a team of international experts operating out of facilities in Mont-Saint-Guibert (Belgium), Durham (NC, USA), Tokyo (Japan) and Basel (Switzerland).
Promethera®, HepaStem®, H2stem®, are all registered trademarks of the PROMETHERA group.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191031005412/en/
Contact:
Promethera Biosciences Japan Branch
Mutsuki Takano, Group CFO / Masumi Akahori, Senior IR Manager
info.japan@promethera.com
Tel: +81 (0)3-5843-6077
Web: www.promethera.com
Distribute your news release with us
-
Print
Our media lists include news desks at all leading Thai and English-language dailies.
-
Radio & TV
We deliver your news to leading Thai radio stations and TV channels.
-
Internet Sites
All releases are submitted to Internet news sites, including several with guaranteed pickup.
Our Self-Serve News Release Couldn't Be Simpler
Our streamlined online process makes it simple and fast to submit your news to the Thai media. Once registered, just enter or copy your text into our submission form and you'll see an instant preview with our fee based on the word count, translation, and any attached image. To confirm submission, hit Enter to be taken to our payment processor. Once payment is approved, your release passes automatically to our news desk for translation and dissemination by our skilled and experienced team. You'll be kept informed at each step of the process.